Cargando…

The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria

BACKGROUND: Pneumococcal disease contributes significantly to childhood morbidity and mortality and treatment is costly. Nigeria recently introduced the pneumococcal conjugate vaccine (PCV) to prevent pneumococcal disease. The aim of this study is to estimate health provider and household costs for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamu, Aishatu Lawal, Karia, Boniface, Bello, Musa M, Jahun, Mahmoud G, Gambo, Safiya, Ojal, John, Scott, Anthony, Jemutai, Julie, Adetifa, Ifedayo M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804652/ https://www.ncbi.nlm.nih.gov/pubmed/35101861 http://dx.doi.org/10.1136/bmjgh-2021-007080

Ejemplares similares

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Nasopharyngeal Pneumococcal Carriage in Nigeria: a two-site, population-based survey
por: Adetifa, Ifedayo M. O., et al.
Publicado: (2018)

Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2017)

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
por: Ojal, John, et al.
Publicado: (2019)

Telling our own story in global health–experience from Nigeria
por: Ihekweazu, Chikwe, et al.
Publicado: (2022)

Prevalence of coccidiosis among village and exotic breed of chickens in Maiduguri, Nigeria
por: Lawal, Jallailudeen Rabana, et al.
Publicado: (2016)

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data
por: Ojal, John, et al.
Publicado: (2017)

High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study
por: Adamu, Aishatu L., et al.
Publicado: (2017)

Crude childhood vaccination coverage in West Africa: Trends and predictors of completeness
por: Kazungu, Jacob S., et al.
Publicado: (2017)

Under-five mortality rate variation between the Health and Demographic Surveillance System (HDSS) and Demographic and Health Survey (DHS) approaches
por: Deribew, Amare, et al.
Publicado: (2016)

Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya
por: Allan, Simon, et al.
Publicado: (2021)

Molecular characterization of Streptococcus pneumoniae causing disease among children in Nigeria during the introduction of PCV10 (GSK)
por: Lo, Stephanie W., et al.
Publicado: (2023)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
por: Webster, Julia, et al.
Publicado: (2011)

Pneumococcal vaccination and childhood pneumonia in South Africa
por: Mulholland, Kim, et al.
Publicado: (2015)

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
por: Hammitt, Laura L, et al.
Publicado: (2019)

The Lancet Nigeria Commission: investing in health and the future of the nation
por: Abubakar, Ibrahim, et al.
Publicado: (2022)

Management of childhood pneumonia in Nigeria
por: Mulholland, Kim
Publicado: (2020)

Pre-Vaccination Nasopharyngeal Pneumococcal Carriage in a Nigerian Population: Epidemiology and Population Biology
por: Adetifa, Ifedayo M. O., et al.
Publicado: (2012)

Mpox (monkeypox) risk and mortality associated with HIV infection: a national case–control study in Nigeria
por: Yinka-Ogunleye, Adesola, et al.
Publicado: (2023)

Enablers and barriers to COVID-19 vaccine uptake in an urban slum in Lagos, Nigeria: informing vaccine engagement strategies for the marginalized
por: Ozoh, Obianuju B, et al.
Publicado: (2023)

COMMUNITY ACQUIRED PNEUMOCOCCAL PNEUMONIA IN NORTHWESTERN NIGERIA: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE AND OUTCOME
por: Iliyasu, Garba, et al.
Publicado: (2017)

The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program
por: Ho, Yi-Chien, et al.
Publicado: (2015)

The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis
por: Adamu, Aishatu Lawal, et al.
Publicado: (2018)

Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia
por: ELEMRAID, M. A., et al.
Publicado: (2013)

Pneumococcal pneumonia
por: Goldblatt, David, et al.
Publicado: (2020)

Time from Illness Onset to Death, 1918 Influenza and Pneumococcal Pneumonia
por: Klugman, Keith P., et al.
Publicado: (2009)

Impact of Preceding Flu-Like Illness on the Serotype Distribution of Pneumococcal Pneumonia
por: Song, Joon Young, et al.
Publicado: (2014)

Population health outcomes in Nigeria compared with other west African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study
por: Angell, Blake, et al.
Publicado: (2022)

Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis
por: Silaba, Micah, et al.
Publicado: (2019)

Ensuring Optimal Community HIV Testing Services in Nigeria Using an Enhanced Community Case-Finding Package (ECCP), October 2019–March 2020: Acceleration to HIV Epidemic Control
por: Jahun, Ibrahim, et al.
Publicado: (2021)

Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
por: Abdullahi, Shehu U., et al.
Publicado: (2023)

Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
por: Wiese, Andrew D., et al.
Publicado: (2016)

What Are the Implications for Childhood Pneumonia of Successfully Introducing Hib and Pneumococcal Vaccines in Developing Countries?
por: Scott, J. Anthony G, et al.
Publicado: (2008)

Vaccination for the control of childhood bacterial pneumonia — Haemophilus influenzae type b and pneumococcal vaccines
por: Otczyk, Diana C., et al.
Publicado: (2016)

Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
por: Tohme, Rania A., et al.
Publicado: (2023)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Investigating Knowledge of Antibiotics, Antimicrobial Resistance and Antimicrobial Stewardship Concepts Among Final Year Undergraduate Pharmacy Students in Northern Nigeria
por: Abdu-Aguye, Samirah N, et al.
Publicado: (2022)

Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation
por: Kebede, Tayue Tateke, et al.
Publicado: (2019)

Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
por: Flasche, Stefan, et al.
Publicado: (2020)

Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa.
por: Thindwa, Deus, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tnbndo73dsakg25k9fonrog76h